Valar Labs Raised $22M Series A

Adin Ermie

California-based, Valar Labs, a AI based cancer care and therapy recommender raised $22 million led by DCVC in a Series A round.

Damir Vrabac (COO) Valar Labs

The round was actively backed  by a16z Bio + Health Andreessen Horowitz  and Pear VC. General Partner and MD Vineeta Agarwala, and DCVC General Partner James Hardiman, will join the Board after this round.

Viswesh Krishna (CTO), Valar Labs

CEO Valar Labs, Anirudh Joshi said that the raised funds will be used for AI advancement and product development.